CARUCCI, SARA
 Distribuzione geografica
Continente #
EU - Europa 36.766
NA - Nord America 3.439
AS - Asia 2.411
SA - Sud America 431
AF - Africa 136
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 43.197
Nazione #
IT - Italia 35.364
US - Stati Uniti d'America 3.296
SG - Singapore 1.009
CN - Cina 629
BR - Brasile 343
SE - Svezia 287
VN - Vietnam 269
FR - Francia 255
DE - Germania 173
FI - Finlandia 125
GB - Regno Unito 113
BD - Bangladesh 97
HK - Hong Kong 97
NL - Olanda 89
ZA - Sudafrica 86
UA - Ucraina 85
IN - India 82
CA - Canada 69
BE - Belgio 59
MX - Messico 42
CH - Svizzera 41
KR - Corea 31
RU - Federazione Russa 30
AR - Argentina 25
ID - Indonesia 25
TR - Turchia 23
AT - Austria 21
RO - Romania 21
CO - Colombia 20
IQ - Iraq 19
ES - Italia 17
MA - Marocco 17
PL - Polonia 17
JP - Giappone 15
MY - Malesia 14
SA - Arabia Saudita 14
AU - Australia 13
EC - Ecuador 13
AE - Emirati Arabi Uniti 12
PK - Pakistan 11
UZ - Uzbekistan 10
VE - Venezuela 10
IE - Irlanda 9
DK - Danimarca 8
GR - Grecia 7
HN - Honduras 7
IL - Israele 7
KE - Kenya 7
NO - Norvegia 7
CL - Cile 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
LT - Lituania 6
DO - Repubblica Dominicana 5
EG - Egitto 5
LB - Libano 5
PY - Paraguay 5
TN - Tunisia 5
BO - Bolivia 4
ET - Etiopia 4
HU - Ungheria 4
IR - Iran 4
JO - Giordania 4
KZ - Kazakistan 4
PH - Filippine 4
PS - Palestinian Territory 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TW - Taiwan 3
AD - Andorra 2
BY - Bielorussia 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
Totale 43.190
Città #
Cagliari 31.753
Uta 1.774
Singapore 579
Ashburn 380
San Jose 267
Rome 215
Boardman 159
Nyköping 159
Council Bluffs 147
Dallas 146
Milan 126
Fairfield 109
Chandler 108
Beijing 101
Woodbridge 98
Los Angeles 97
Houston 91
Helsinki 86
Hong Kong 85
New York 84
Ho Chi Minh City 81
Santa Clara 71
Hefei 66
Johannesburg 62
The Dalles 56
Hanoi 55
Genk 50
Ann Arbor 47
Lauterbourg 45
Dearborn 44
Cambridge 43
Bari 42
Charleston 42
Jacksonville 42
Wilmington 42
Shanghai 41
Palermo 40
Frankfurt am Main 39
Turin 37
Dong Ket 34
Seattle 33
São Paulo 33
Naples 32
Florence 31
Chicago 30
Bologna 29
Orem 29
Boston 28
Redondo Beach 28
Seoul 26
Catania 24
Nanjing 24
Amsterdam 23
San Diego 22
Munich 21
Nuremberg 21
Washington 21
Buffalo 19
Atlanta 18
Messina 17
Padova 17
Brescia 16
Bucharest 16
Mexico City 16
San Francisco 16
Silver Spring 16
Brooklyn 15
Castellammare di Stabia 15
Phoenix 15
Ancona 14
Lappeenranta 14
Montreal 14
Taranto 14
Rotterdam 13
Rustenburg 13
Cincinnati 12
Da Nang 12
Guangzhou 12
London 12
Parma 12
Stockholm 12
Tokyo 12
Toronto 12
Calgary 11
Chennai 11
Genoa 11
Haiphong 11
Perugia 11
Tianjin 11
Trieste 11
Urbino 11
Utrecht 11
Zurich 11
Denver 10
Mumbai 10
Salvador 10
Warsaw 10
Casablanca 9
Changsha 9
Dhaka 9
Totale 38.549
Nome #
Effetti del Metilfenidato sulla crescita in bambini e adolescenti ADHD. Revisione sistematica e monitoraggio prospettico a lungo termine dei parametri auxologici: analisi preliminari dei risultati dello studio europeo di farmacovigilanza ADDUCE 2.113
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.883
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.643
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.603
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.567
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.518
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.367
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.266
null 1.154
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.147
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.057
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 1.028
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 935
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 863
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 817
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 809
null 754
null 750
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 749
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 741
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 729
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 725
null 689
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 682
null 675
Disturbo Bipolare in età evolutiva: caratteristiche cliniche ed efficacia della terapia farmacologica 675
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies 662
null 658
Eziologia 623
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 608
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 578
Association of Risk of Suicide Attempts With Methylphenidate Treatment 573
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 571
null 549
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 549
Management and treatment of attention-deficit/hyperactivity disorder 540
Methylphenidate effects on social functioning in children with ADHD 538
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 498
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 461
Tolerability and safety of risperidone in childhood: may specific clinical variables predict extrapyramidal averse events? 452
Face and emotion recognition in children with ADHD and autism spectrum disorders: effects of methylphenidate 442
EffEtti sulla crescita della terapia a lungo termine con metilfenidato in bambini e adolescenti con disturbo da deficit di attenzione e iperattività (ADHD) 438
Contemporary diagnosis and treatment of conduct disorder in youth 358
Phenomenology and 24 month treatment outcome of pediatric bipolar disorder 329
Neurofeedback for Attention-Deficit/Hyperactivity Disorder 316
Long term therapy with methylphenidate induces modest effects on growth in ADHD children 311
Tolerability, safety and efficacy of long term (at least 6 months) quetiapine and aripiprazole in children and adolescents 293
Neuropsychiatric diseases of the basal ganglia: obsessive compulsive disorder, ADHD and Tourette Syndrome Neurobiology 291
Predictive factors for persistent use and compliance of immediate-release methylphenidate: A 36-month naturalistic study 288
Growth on stimulant medication: effects in children with ADHD 273
Neurobiologia della Depressione in Età Evolutiva 270
Emotion recognition and social functioning in children with ADHD or autism spectrum disorders 258
Emotional dysregulation, executive functions and callous-unemotional traits in children and adolescents with Oppositional Defiant Disorder/Conduct Disorder and Autism Spectrum Disorder: a direct comparison 213
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project 198
Pandemic-related emergency psychiatric presentations for self-harm of children and adolescents in 10 countries (PREP-kids): a retrospective international cohort study 184
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 167
Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update 162
ABA: l’analisi comportamentale applicata 161
Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder 151
Psicoterapia a indirizzo cognitivo-comportamentale 148
Methylphenidate and ADHD|Metilfenidato e ADHD 142
An Evolutionary Preamble Towards a Multilevel Framework to Understand Adolescent Mental Health: An International Delphi Study 141
Professor Alessandro Zuddas’ Impact and Legacy: The Influential Networking and Human Connection Skills of a Passionate Scientist, Clinical Academic, and Pioneer in Child and Adolescent Psychopharmacology 139
Psychopharmacology in children and adolescents: unmet needs and opportunities 137
Lockdown stringency and paediatric self-harm presentations during COVID-19 pandemic: retrospective cohort study 134
Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes 132
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study 131
REM sleep atonia in patients with pediatric acute-onset neuropsychiatric syndrome (PANS): implications for pathophysiology 130
COVID-19 Pandemic School Disruptions and Acute Mental Health in Children and Adolescents 127
Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic 124
Neurodevelopmental Disorders and Suicide: A Narrative Review 120
Social and executive functioning in individuals with autism spectrum disorder without intellectual disability: The case–control study protocol of the CNeSA study 109
Neuropsichiatria infantile 107
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents 103
Self-Harm in Children and Adolescents Who Presented at Emergency Units During the COVID-19 Pandemic: An International Retrospective Cohort Study 101
An International Clinical Study of Ability and Disability in Autism Spectrum Disorder Using the WHO-ICF Framework 90
Editorial: Two Centimeters More or Less. How Much Does It Matter to an Adolescent or a Young Adult With Attention-Deficit/Hyperactivity Disorder? 75
Il disturbo oppositivo provocatorio 73
Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease 64
RISPERIDONE 63
Posttraumatic disorder, eye movement desensitization and reprocessing (EMDR) 60
Suicidal risk and psychopathological profiles in adolescents with neurodevelopmental disorders: an Italian multicentric study 60
Attention deficit hyperactivity disorder symptoms and risky sexual behaviours in university students:the i-Share study 8
Comparing the Metabolic Profile of Patients Affected by Acute-Onset Neuropsychiatric Syndrome PANS and Tourette Syndrome: Preliminary Data 6
Totale 43.426
Categoria #
all - tutte 65.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.048


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021380 0 0 0 0 0 0 0 0 0 0 0 380
2021/20222.372 155 110 68 274 228 144 98 153 267 294 311 270
2022/20235.496 277 539 541 404 402 496 278 659 406 370 726 398
2023/20246.417 327 259 242 377 716 969 991 430 345 479 674 608
2024/202512.299 2.055 2.880 1.780 1.527 809 792 1.151 103 213 172 463 354
2025/20266.584 489 311 530 519 576 482 953 686 499 824 499 216
Totale 43.426